Figure 6
Figure 6. Long-term hematopoiesis-reconstituting activity is excusive to ESAMHi fraction. (A) The Rag1/GFP− Sca1+ c-kitHi cells (CD45.2+) of E14.5 fetal liver were sorted into 2 fractions, ESAM−/Lo and ESAMHi. Then, 1000 cells of each fraction were mixed with 2 × 105 CD45.1+ whole adult bone marrow cells of 10-week-old mice and transplanted to a lethally irradiated CD45.1 mouse (A). (B) Flow cytometry analyses for peripheral leukocytes were performed at 5 weeks after transplantation. In the 2 independent experiments, 9 of 11 recipients with ESAMHi cells were clearly reconstituted by CD45.2+ cells (> 1.0% in all of myeloid, T, and B lineages), whereas none of 11 recipients with ESAM−/Lo cells had CD45.2+ cells detectable in the flow cytometry. The figure shows representative results in each group. (C,D) Twenty weeks after transplantation, all the recipients were killed, and the contribution of CD45.2+ ESAMHi cells was evaluated in lymphohematopoietic organs. Percentages of CD45.2+ CD45.1− population among total CD45+ cells in bone marrow of each recipient were plotted (C). The long-term reconstitution of CD45.2+ ESAMHi cells was confirmed with respect to myeloid, B lymphoid, or T lymphoid lineages in the bone marrow, spleen, and thymus, respectively (D).

Long-term hematopoiesis-reconstituting activity is excusive to ESAMHi fraction. (A) The Rag1/GFP Sca1+ c-kitHi cells (CD45.2+) of E14.5 fetal liver were sorted into 2 fractions, ESAM−/Lo and ESAMHi. Then, 1000 cells of each fraction were mixed with 2 × 105 CD45.1+ whole adult bone marrow cells of 10-week-old mice and transplanted to a lethally irradiated CD45.1 mouse (A). (B) Flow cytometry analyses for peripheral leukocytes were performed at 5 weeks after transplantation. In the 2 independent experiments, 9 of 11 recipients with ESAMHi cells were clearly reconstituted by CD45.2+ cells (> 1.0% in all of myeloid, T, and B lineages), whereas none of 11 recipients with ESAM−/Lo cells had CD45.2+ cells detectable in the flow cytometry. The figure shows representative results in each group. (C,D) Twenty weeks after transplantation, all the recipients were killed, and the contribution of CD45.2+ ESAMHi cells was evaluated in lymphohematopoietic organs. Percentages of CD45.2+ CD45.1 population among total CD45+ cells in bone marrow of each recipient were plotted (C). The long-term reconstitution of CD45.2+ ESAMHi cells was confirmed with respect to myeloid, B lymphoid, or T lymphoid lineages in the bone marrow, spleen, and thymus, respectively (D).

Close Modal

or Create an Account

Close Modal
Close Modal